Laparoscopic Radical Prostatectomy With the Heilbronn Technique: Oncological Results in the First 500 Patients

Abstract

At centers of expertise laparoscopic radical prostatectomy may provide an oncological outcome similar to that of the open procedure. However, it offers the advantages of minimally invasive surgery.

Laparoscopic radical prostatectomy: oncological and functional results of 126 patients with a minimum 3-year follow-up at a single Chinese institute

“…Notably, the functional outcomes in this study seem to be better than those of several previous reports [22][23][24][25]. Although wide disparity exists in the reported continence and erectile function after LRP, which could result from differing definitions of continence and erectile function, surgical techniques and qualityof-life instruments used, there is possible observerreceiver bias when evaluating the functional results by outpatient or telephone interviews.…”

“…bPFS might offer a better index of oncological outcome. Previous series of LRP reporting bPFS are shown in Table 5 and are compared with large ORP series [18,[22][23][24][27][28][29]. The bPFS rates in the present series at 3-year followup, of 90% for pT2, 61% for pT3a and 43.0% for pT3b, respectively, are comparable with both open and laparoscopic series with a similar duration of follow-up.…”

“…When neurovascular bundles were preserved during LRP, the reported penile erectile rates were 33%-85% [18][19][20][21][22][23]. In this study, it was 51.9% at 1 year and 81.5% at 3 years after surgery.…”

“…The reported rates of urinary continence after LRP compare favorably with those in large series of ORP, which have been reported to be 80%-95%. Although the definition of urinary continence varies among the reported series, the incidence of requiring no pads after LRP was 83%-100% at 1 year [22][23][24][25]. In a prospective comparison of 70 patients with ORP and 230 with LRP, there was no significant difference in continence at 1 year, but patients undergoing LRP had an earlier return to continence [23].…”

“…The oncological data available from comparative studies show that LRP apparently gives results of similar percentages of PSM to those of ORP [18][19][20][21][22][23][24][25][26][27][28][29][30] (Table 4). The PSM rates for LRP in pT2 and pT3 disease were 7.4%-27.5% and 17.2%-77.3%, respectively, and for ORP in pT2 and pT3 disease were 3.3%-18.8% and 19.3%-53%, respectively.…”